ASX:RVSRevasum Cdi 1:1 US Prohibited Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Revasum Cdi 1:1 US Prohibited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$0.33MA: A$0.63▼A$0.8652-Week Range N/AVolume10,526 shsAverage VolumeN/AMarket Capitalization$25.76 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Revasum, Inc. designs, develops, manufactures, and markets a portfolio of semiconductor processing equipment worldwide. The company offers grinding, polishing, and chemical mechanical planarization equipment to manufacture microchips, sensors, LEDs, and RF and power devices, which are used in IoT devices, cellphones, wearables, automotive, and 5G and industrial applications. It also provides wafer processing equipment for device and substrate manufacturing; and spare parts kits, on-site and off-site training, and training services. Revasum, Inc. was founded in 2016 and is headquartered in San Luis Obispo, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Revasum Cdi 1:1 US Prohibited. Previous Next 0.6 Community Rank Outperform VotesRevasum Cdi 1:1 US Prohibited has received 18 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRevasum Cdi 1:1 US Prohibited has received 124 “underperform” votes. (Add your “underperform” vote.)Community SentimentRevasum Cdi 1:1 US Prohibited has received 87.32% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Revasum Cdi 1:1 US Prohibited and other stocks. Vote “Outperform” if you believe RVS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RVS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRevasum Cdi 1:1 US Prohibited does not currently pay a dividend.Dividend GrowthRevasum Cdi 1:1 US Prohibited does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Revasum Cdi 1:1 US Prohibited insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Revasum Cdi 1:1 US Prohibited is -1.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Revasum Cdi 1:1 US Prohibited is -1.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 0.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.12 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Semiconductor Equipment & Materials Sub-IndustryN/A SectorComputer and Technology Current SymbolASX:RVS Previous Symbol CUSIPN/A CIKN/A Webwww.revasum.com Phone805-541-6424Debt Debt-to-Equity Ratio21.75 Current Ratio2.49 Quick Ratio1.10Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$20.51 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.55 Book ValueA$0.27 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees106 Outstanding Shares78,045,904Market Cap$25.76 million Next Earnings DateN/A OptionableNot Optionable Receive RVS News and Ratings via Email Sign-up to receive the latest news and ratings for RVS and its competitors with MarketBeat's FREE daily newsletter. Revasum Cdi 1:1 US Prohibited (ASX:RVS) Frequently Asked Questions Has Revasum Cdi 1:1 US Prohibited been receiving favorable news coverage? News stories about RVS stock have been trending negative on Sunday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Revasum Cdi 1:1 US Prohibited earned a news impact score of -2.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news about Revasum Cdi 1:1 US Prohibited. Who are some of Revasum Cdi 1:1 US Prohibited's key competitors? Some companies that are related to Revasum Cdi 1:1 US Prohibited include Nanoco Group (NANO), eMagin (EMAN), CML Microsystems (CML), eMagin (EMAN), BluGlass (BLG), Trio-Tech International (TRT), Aixtron (AIXXF), Asahi Group (ASMVF), Chow Tai Fook Jewellery Group (ASMVY), Meyer Burger Technology (MYBUF), Nanoco Group (NNOCF), Nordic Semiconductor ASA (NDCVF), Solitron Devices (SODI) and Terrascend (TER). View all competitors. Who are Revasum Cdi 1:1 US Prohibited's key executives? Revasum Cdi 1:1 US Prohibited's management team includes the following people: Mr. Jerauld J. Cutini, Exec. Chairman, Pres & CEO (Age 60)Mr. Ryan A. Benton, Sr. VP, CFO, Company Sec. & Exec. Director (Age 48)Mr. David Roeloffs, VP of OperationsDr. Robert Rhoades, Chief Technology OfficerMs. Sarah Okada, VP of Marketing & Product Management What is Revasum Cdi 1:1 US Prohibited's stock symbol? Revasum Cdi 1:1 US Prohibited trades on the ASX under the ticker symbol "RVS." How big of a company is Revasum Cdi 1:1 US Prohibited? Revasum Cdi 1:1 US Prohibited has a market capitalization of $0.00 and generates $20.51 million in revenue each year. Revasum Cdi 1:1 US Prohibited employs 106 workers across the globe. What is Revasum Cdi 1:1 US Prohibited's official website? The official website for Revasum Cdi 1:1 US Prohibited is www.revasum.com. How can I contact Revasum Cdi 1:1 US Prohibited? The company can be reached via phone at 805-541-6424. This page was last updated on 7/12/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
